Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
44%(4 trials)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
2
22%
Ph phase_1
1
11%
Ph phase_2
5
56%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
5(55.6%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(9)

Detailed Status

Completed9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 25 (55.6%)
Phase 31 (11.1%)
N/A2 (22.2%)

Trials by Status

completed9100%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_1

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism

NCT02552147
completedphase_2

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

NCT02312934
completednot_applicable

Coping Skills Treatment for Smoking Cessation

NCT01061528
completedphase_2

Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation

NCT01484717
completedphase_3

Pharmacogenetics of Nicotine Addiction Treatment

NCT01314001
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT02552147Phase 1

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism

Completed
NCT02312934Phase 2

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Completed
NCT01061528Not Applicable

Coping Skills Treatment for Smoking Cessation

Completed
NCT01484717Phase 2

Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation

Completed
NCT01314001Phase 3

Pharmacogenetics of Nicotine Addiction Treatment

Completed
NCT00873392Phase 2

Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease

Completed
NCT00018148Phase 2

Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation

Completed
NCT01085032Phase 2

Nicotine Patch Trial in Syrian Primary Care Settings

Completed
NCT00018213Not Applicable

Naltrexone and Patch for Smokers

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9